username: password:     Join free | Forgot password
Add to favorites    中文
home > news and events
15th Annual Drug Discovery Summit - New Hot Topics Announced

Clicks:431 Date:04/25/14

Oxford Global are pleased to announce the return of the Pharma R&D Europe Series, the leading pharmaceutical discussion forum in Europe.The first round of topics have now been confirmed for the 15th Annual Drug Discovery Summit, taking place on the 2nd & 3rd June 2014 in Geneva, Switzerland. Co-located with our 2nd Annual Discovery Chemistry congress
15th Annual Drug Discovery Summit 2014
2nd & 3rd June 2014, Geneva, Switzerland
http://www.drugdiscovery-summit1.com/

Oxford Global are pleased to announce the return of the Pharma R&D Europe Series, the leading pharmaceutical discussion forum in Europe.

The series is made up of the following events:
15th Annual Drug Discovery Summit
6th Annual Drug Development Congress
2nd Annual Discovery Chemistry & Drug Design Congress

The first round of topics have now been confirmed for the 15th Annual Drug Discovery Summit, taking place on the 2nd & 3rd June 2014 in Geneva, Switzerland. Co-located with our 2nd Annual Discovery Chemistry congress, the 15th Annual Drug Discovery Summit topics include:

Diversity Screening at AstraZeneca: Lead Generation Through Internal Delivery and External Collaboration
Development of the diversity screening strategy for 2014-2017
Enabling a capability for phenotypic discovery
Leveraging capability for Open Innovation

CONFIRMED SPEAKER:
Steve Rees, Vice President, Screening Sciences and Sample Management, AstraZeneca

Disease Modeling And Phenotypic Drug Screening For Diabetic Cardiomyopathy Using Human Induced Pluripotent Stem Cells
Diabetic cardiomyopathy can be induced in vitro by environmental or genetic means
The extent of patient-specific cardiomyopathy is clinically correlated
Phenotypic screening identifies drugs that rescue the disease phenotype

Roberto Iacone, Group Head, Roche-Basel

3D and Phenotypic Screening: Where Do We Go In The Third Dimension?
Relevance of cellular models for drug discovery
Infrastructure for 3D and Phenotypic screening
Outcome comparison for 2D and 3D screening

Adam Hill, Director, Head of Screening, Novartis

Our speaker programmes have been carefully researched, ensuring delegates are exposed to the highest level of expertise. Confirmed speakers so far include:
Steve Rees, Vice President, Screening Sciences and Sample Management, AstraZeneca
Robert Hayes, Vice President and Venture Leader, Centyrex Venture, Janssen
Richard Sedrani, Executive Director, CPC / Expertise Platform Proteases / Medicinal Chemistry Unit, Novartis
Ashwani Bahl, Senior Director Global External Research & Development, Eli Lilly
Eckhard Ottow, Head Global External Innovation & Alliances Global Drug Discovery, Bayer HealthCare Pharmaceuticals
Charlotte Deane, Director of the Systems Approaches to Biomedical Sciences Industrial DTC, Oxford University

To find out who else will be speaking at this two-day event, visit (http://www.drugdiscovery-summit1.com/speakers/)

Register your interest today to hear over 55 outstanding case studies and presentations, across 6 interactive streams:
R&D Models For The Future
Screening & Assays: Enabling Technologies
Target Based Discovery
Supporting Innovation: Data & Information Management
Discovery Chemistry: Latest Case Studies
Drug Design: Novel Approaches

Download the conference programme and view this two day event in more detail.
(http://www.drugdiscovery-summit1.com/download-agenda-marketing/)

Your booking will give you free access to the 6th Annual Drug Development Congress and the 2nd Annual Discovery Chemistry & Drug Design Congress

The Discovery Chemistry & Drug Design Congress proved a popular addition to the summit last year. This year the congress will include key case studies in chemical genetics, computational chemistry and flow chemistry. Presentations will also focus on early de-risking through drug design, focusing on the areas such as solubility, potency and selectivity.

Limited discounted places are available. Contact Danielle Dalby on +44(0) 1865 248455 or email mailto:d.dalby@oxfordglobal.co.uk for more information.

Related News>> more
advertisement

Copyright(C) 2006-2014 bio-equip    E-mail:web@bio-equip.cn   娌狪CP澶06040519鍙